“Cost–Benefit Evaluation of Interferon and Ribavirin for the Treatment of Hepatitis C in District Dera Ismail Khan, Pakistan”. 2026. Physical Education, Health and Social Sciences 4 (1): 129-36. https://doi.org/10.63163/jpehss.v4i1.1040.